RxDoctor Payments Data

Jessica Acosta

Family · Phoenix, AZNPI 1598011785

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,850 of the $30,044 with a category attached, or 62.7%. 25 manufacturers reported payments, led by GSK at 43.8% of the total. Reporting peaked in 2022 at $14,123 and has fallen 99.3% since, to $95 in 2025. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,044in general payments, 2019–2025

Across 91 payments — averaging $330.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$13K
  • Pharmacyclics LLC, An Abbvie Company$12K
  • Johnson & Johnson$2K
  • Novartis$897
  • Gilead$352
  • AbbVie$247
  • plus $2K from 19 others

What the payments were for

  • Speaking & faculty fees$18,85063%
  • Travel & lodging$5,27318%
  • Food & beverage$4,85116%
  • Education$1891%
  • Other$8813%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,044 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →